...
首页> 外文期刊>Advanced Biomedical Research >Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats
【24h】

Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats

机译:Securigera securidaca种子水醇提取物对链脲佐菌素诱导的糖尿病大鼠的降血糖和降血脂作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Hyperlipidemia is an associated complication of diabetes mellitus. Lowering of serum lipid levels seems to be associated with a decrease in the risk of vascular disease and related complications. The purpose of the current study was to evaluate the antihyperglycemic and antihyperlipidemic effects of the hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats. Materials and Methods: Female Wistar rats were randomly divided into four groups as follows: Control, diabetic, and diabetic rats treated with the Securigera extract at doses of 100 and 200 mg/kg. The animals were rendered diabetic by a single intraperitoneal injection of 55 mg/kg streptozotocin. Diabetic rats received the Securigera extract daily in drinking water from the day on which diabetes was confirmed for 4 weeks. The levels of serum glucose and lipids were spectrophotometrically measured in all groups at weeks 0 (before diabetes induction), 2, and 4. Results: The results showed that there was a significant increase in serum glucose, triglycerides, total cholesterol, and low density lipoprotein (LDL)-cholesterol in streptozotocin-induced diabetic rats, accompanied by a decrease in high density lipoprotein (HDL)-cholesterol. Treatment of diabetic rats with S. securidaca seed extract at a dose of 200 mg/kg over a 4-week period significantly reduced the levels of serum glucose, total cholesterol, and LDL-cholesterol and increased the level of HDL-cholesterol, compared to diabetic untreated rats. Conclusions: Securigera extract at a dose of 200 mg/kg exhibited hypoglycemic and hypolipidemic activities in streptozotocin-diabetic rats during the 4-week treatment period. This provides a valid scientific basis for using it in the treatment of diabetes in Iranian folk medicine.
机译:背景:高脂血症是糖尿病的相关并发症。降低血清脂质水平似乎与降低血管疾病和相关并发症的风险有关。本研究的目的是评估链脲佐菌素诱导的糖尿病大鼠中Securigera securidaca种子的水醇提取物的降血糖和降血脂作用。材料和方法:将雌性Wistar大鼠随机分为四组:对照组,糖尿病大鼠和用Securigera提取物以100和200 mg / kg的剂量治疗的糖尿病大鼠。通过单次腹膜内注射55mg / kg链脲佐菌素使动物患有糖尿病。从确认患有糖尿病的那一天起,糖尿病大鼠每天从饮用水中接受Securigera提取物。在第0周(诱导糖尿病前),第2和第4周,用分光光度法测量了所有组的血清葡萄糖和脂质水平。结果:结果表明,血清葡萄糖,甘油三酸酯,总胆固醇和低密度蛋白显着增加链脲佐菌素诱导的糖尿病大鼠体内脂蛋白(LDL)-胆固醇降低,高密度脂蛋白(HDL)-胆固醇降低。与4周相比,以200 mg / kg剂量的seccuridaca种子提取物治疗糖尿病大鼠显着降低了血清葡萄糖,总胆固醇和LDL-胆固醇的水平,并增加了HDL-胆固醇的水平未治疗的糖尿病大鼠。结论:200 mg / kg剂量的Securigera提取物在4周治疗期间对链脲佐菌素-糖尿病大鼠具有降血糖和降血脂的作用。这为将其用于伊朗民间医学中的糖尿病治疗提供了有效的科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号